Home › Pharmaceuticals › Clinical Diagnostics
Clinical Diagnostics Market Research Reports & Consulting
Market Reports
| Title | Published | Price | TOC Available |
|---|---|---|---|
Clinical Trial Imaging Market by Modality (CT, MRI, PET, Ultrasound, Echocardiography, X-Ray), Product & Services (Software), End User (Pharmaceutical Companies, Biotechnology Companies, CROs, Medical Device Manufacturers) - Global Forecast to 2021The global market for clinical trial imaging is projected to reach $1069.7 million by 2021 from $773.4 million in 2016, at a CAGR of 6.7% from 2016 to 2021.In this report, the global clinical trial imaging market is broadly segmented by product and service, modality, end user, and region. Both, top-down and bottom-up approaches were used to validate the size of the global clinical trial imaging market and estimate the size of various other dependent submarkets. Major players in the market were identified through secondary research and their market presence was studied through primary and secondary research. |
December 2016 | $ 4950 |
|
Blood Culture Test Market Size & Share by Application (Bacteremia, Fungemia), Product (Consumables, Instrument), Method (Automated, Manual), Technology (PCR, Microarray, Proteomic) & End User (Hospital Laboratories, Reference Laboratories) - Global Forecast to 2021The overall market for blood culture test is projected to reach $4,768.9 million by 2021 from $3, 252.6 million in 2016, at a CAGR of 8.0% during the forecast period. The base year considered for the study is 2015 and the forecast for the market size of blood culture test is provided for the period between 2016 and 2021.This report aims to estimate the market size and future growth potential of the global market across different segments such as method, product, technology, application, end user, and region. Factors such as rising aging population, increase in product approvals and launches, growing number of sepsis cases, high incidence of bloodstream infections (BSI), increase in demand for rapid diagnostic techniques, and high prevalence of infectious diseases are driving the market growth of blood culture test. |
July 2016 | $ 4950 |
|
Biochips Market Size & Share by Type (DNA Chip (Genomics, Drug Discovery, Gene Expression) Lab-on-a-chip (IVD & POC, Proteomics), Protein Chips), Fabrication Technology (Microarrays, Microfluidics), End user (Academics Institutes, Diagnostics Centers) - Global Forecast to 2020is 2015 and the forecast for the market size is provided for the period between 2015 and 2020. In the current market scenario, biochips are increasingly adopted in various applications in the field of genomics, drug discovery, and proteomics. In addition, the development of targeted and personalized medicines for the treatment of cancer and technological advancements in biochips are also supporting the growth of biochip products. |
May 2016 | $ 4950 |
|
Global Clinical Trials Market (Key Therapeutic Categories, Country Wise Metrics & Regulatory Approval Framework)This research report categorizes the Global Clinical Trials Market on the basis of phases, indications, and study design analyzing trends in each. Each section will provide market data, market drivers, trends and opportunities, key players, and competitive outlook. This report will also provide more than 20 company profiles. |
September 2011 | $ 4950 |
|
US Neonatal (Preterm) Infant Care Market (2010-2015)Preterm infant care forms a significant part of the pediatric healthcare market in U.S as preterm births are on a alarming rise in the nation. Preterm births are one of the leading causes of infant mortality in U.S with 1 in 8 births being preterm. Induced fertility and labor treatments, poor prenatal care, inappropriate maternal age, obesity, smoking are some of the major reasons responsible for increasing incidence of preterm births in the country. Preterm infant care products such as infant care devices, infant formula and drugs face a great demand in United States due to the absolute necessity of such products in sustaining baby lives. The products are indispensable in saving preterm babies because they are biologically immature and require external medical assistance in the form of respiratory, nutritional and thermal control support for survival. Infant care products have helped to increase the survival of preterm babies in the country. The criticality of the products in preterm infant care is driving the market. Furthermore, technology advances in regards to multi function equipments are also propelling the growth of the market. |
March 2011 | $ 4950 |
|
Custom Market Research Services
We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.
Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement
Connect With Us
Search reports
Pharmaceuticals ›
Information and Communications Technology ›
Semiconductor and Electronics ›
Medical Devices ›
Chemicals ›
Advanced Materials ›
Energy and Power ›
Food and Beverage ›
Biotechnology ›
Aerospace and Defence ›
Healthcare IT ›
Automotive and Transportation ›
Automation and Process Control ›
Agriculture Industry ›
Packaging ›
Building and Construction ›
Mining, Minerals and Metals ›
Analytical and Scientific Instrumentation ›
Engineering Equipment and Devices ›
'Connect With Us
